Skip to main content

Advertisement

Figure 1 | Reproductive Biology and Endocrinology

Figure 1

From: Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction

Figure 1

Treatment protocols. aWhen the leading follicle reached ≥17 mm and no more than two follicles had reached >14 mm, a single dose of hCG was injected to trigger ovulation. bDuration of ovarian stimulation could not exceed 35 days, unless ultrasound assessment suggested imminent follicular growth and maturation. The maximum permitted daily dose of r-hFSH was 225 IU. Ovarian response was monitored by TVUS every 7 days until a follicle of ≥10 mm was observed, and then scheduled according to local practice. hCG = human chorionic gonadotrophin; IU, international units; r-hFSH = recombinant human follicle-stimulating hormone; TVUS, trans-vaginal ultrasound.

Back to article page